ABSTRACT
Protein
kinase B (PKB/Akt) is an important modulator of insulin signaling, cell
proliferation, and survival. Using small interfering RNA duplexes in
nontransformed mammalian cells, we show that only Akt1 is essential for
cell proliferation, while Akt2 promotes cell cycle exit. Silencing Akt1
resulted in decreased cyclin A levels and inhibition of S-phase entry,
effects not seen with Akt2 knockdown and specifically rescued by
microinjection of Akt1, not Akt2. In differentiating myoblasts, Akt2
knockout prevented myoblasts from exiting the cell cycle and showed
sustained cyclin A expression. In contrast, overexpression of Akt2
reduced cyclin A and hindered cell cycle progression in M-G1
with increased nuclear p21. p21 is a major target in the differential
effects of Akt isoforms, with endogenous Akt2 and not Akt1 binding p21
in the nucleus and increasing its level. Accordingly, Akt2 knockdown
cells, and not Akt1 knockdown cells, showed reduced levels of p21. A
specific Akt2/p21 interaction can be reproduced in vitro, and the Akt2
binding site on p21 is similar to that in cyclin A spanning T145 to
T155, since (i) prior incubation with cyclin A prevents Akt2 binding,
(ii) T145 phosphorylation on p21 by Akt1 prevents Akt2
binding, and (iii) binding Akt2 prevents phosphorylation of p21 by
Akt1. These data show that specific interaction of the Akt2 isoform
with p21 is key to its negative effect on normal cell cycle
progression.